Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-13

Clinical Trial Update: Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

View source ↗

Summary

An observational study evaluating the efficacy and safety of liraglutide in adults with type 2 diabetes has completed. The study was sponsored by Novo Nordisk A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED